131 related articles for article (PubMed ID: 10608711)
1. Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis.
Desiderio C; Rudaz S; Raggi MA; Fanali S
Electrophoresis; 1999 Nov; 20(17):3432-8. PubMed ID: 10608711
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-assisted dispersive liquid-liquid microextraction coupled with field-amplified capillary electrophoresis for sensitive and quantitative determination of fluoxetine and norfluoxetine enantiomers in biological fluids.
Wang ZR; Hsieh MM
Anal Bioanal Chem; 2020 Aug; 412(21):5113-5123. PubMed ID: 32162085
[TBL] [Abstract][Full Text] [Related]
3. Direct stereoselective assay of fluoxetine and norfluoxetine enantiomers in human plasma or serum by two-dimensional gas-liquid chromatography with nitrogen-phosphorus selective detection.
Ulrich S
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(2):481-90. PubMed ID: 12482491
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
Kim J; Riggs KW; Misri S; Kent N; Oberlander TF; Grunau RE; Fitzgerald C; Rurak DW
Br J Clin Pharmacol; 2006 Feb; 61(2):155-63. PubMed ID: 16433870
[TBL] [Abstract][Full Text] [Related]
5. A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patients.
Sabbioni C; Bugamelli F; Varani G; Mercolini L; Musenga A; Saracino MA; Fanali S; Raggi MA
J Pharm Biomed Anal; 2004 Oct; 36(2):351-6. PubMed ID: 15496328
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrins.
Rudaz S; Stella C; Balant-Gorgia AE; Fanali S; Veuthey JL
J Pharm Biomed Anal; 2000 Aug; 23(1):107-15. PubMed ID: 10898160
[TBL] [Abstract][Full Text] [Related]
7. Chiral separation of highly negatively charged enantiomers by capillary electrophoresis.
Liu Q; Inoue T; Kirchhoff JR; Huang C; Tillekeratne LM; Olmstead K; Hudson RA
J Chromatogr A; 2004 Apr; 1033(2):349-56. PubMed ID: 15088757
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard.
Li C; Ji Z; Nan F; Shao Q; Liu P; Dai J; Zhen J; Yuan H; Xu F; Cui J; Huang B; Zhang M; Yu C
Rapid Commun Mass Spectrom; 2002; 16(19):1844-50. PubMed ID: 12271449
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of fluoxetine in the clinical treatment setting.
Lundmark J; Reis M; Bengtsson F
Ther Drug Monit; 2001 Apr; 23(2):139-47. PubMed ID: 11294514
[TBL] [Abstract][Full Text] [Related]
10. Micellar electrokinetic capillary chromatography for the determination of fluoxetine and its metabolite norfluoxetine in biological fluids.
Berzas Nevado JJ; Contento Salcedo AM; Villaseñor Llerena MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Apr; 769(2):261-8. PubMed ID: 11996492
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous identification and quantitation of fluoxetine and its metabolite, norfluoxetine, in biological samples by GC-MS.
Crifasi JA; Le NX; Long C
J Anal Toxicol; 1997 Oct; 21(6):415-9. PubMed ID: 9323519
[TBL] [Abstract][Full Text] [Related]
12. Use of vancomycin silica stationary phase in packed capillary electrochromatography. II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma.
Fanali S; Rudaz S; Veuthey JL; Desiderio C
J Chromatogr A; 2001 Jun; 919(1):195-203. PubMed ID: 11459304
[TBL] [Abstract][Full Text] [Related]
13. Enantiomeric separation of methamphetamine and related analogs by capillary zone electrophoresis: intelligence study in routine methamphetamine seizures.
Cheng WC; Lee WM; Chan MF; Tsui P; Dao KL
J Forensic Sci; 2002 Nov; 47(6):1248-52. PubMed ID: 12455645
[TBL] [Abstract][Full Text] [Related]
14. Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.
LLerena A; Dorado P; Berecz R; González A; Jesús Norberto M; de la Rubia A; Cáceres M
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):25-31. PubMed ID: 12450521
[TBL] [Abstract][Full Text] [Related]
15. Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detection.
Alvarez JC; Bothua D; Collignon I; Advenier C; Spreux-Varoquaux O
J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):175-80. PubMed ID: 9613947
[TBL] [Abstract][Full Text] [Related]
16. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection.
Orsulak PJ; Kenney JT; Debus JR; Crowley G; Wittman PD
Clin Chem; 1988 Sep; 34(9):1875-8. PubMed ID: 3262022
[TBL] [Abstract][Full Text] [Related]
17. Chiral high-performance liquid chromatographic analysis of fluoxetine and norfluoxetine in rabbit plasma, urine, and vitreous humor using an acetylated beta-cyclodextrin column.
Yee L; Wong SH; Skrinska VA
J Anal Toxicol; 2000 Oct; 24(7):651-5. PubMed ID: 11043675
[TBL] [Abstract][Full Text] [Related]
18. Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin.
Neudeck BL; Taddonio TE; Garner WL; Welage LS
Pharmacotherapy; 1998; 18(4):851-5. PubMed ID: 9692660
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.
Eap CB; Gaillard N; Powell K; Baumann P
J Chromatogr B Biomed Appl; 1996 Jul; 682(2):265-72. PubMed ID: 8844419
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.
Jannuzzi G; Gatti G; Magni P; Spina E; Pacifici R; Zuccaro P; Torta R; Guarneri L; Perucca E
Ther Drug Monit; 2002 Oct; 24(5):616-27. PubMed ID: 12352933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
